Join us to learn more about surgical innovations, best practices to optimize patient outcome, the future of digital surgery, and more on November 2. Registration is open to physicians, physicians assistants, registered nurses and nurse practitioners: mshs.co/3MaiMl2

GREAT WORK by Sarah James Murrough, et al. 'highlights the key role of the threat circuitry in #Depression & its assoc w/ #Inflammation , suggesting that novel treatments should target the #ImmuneSystem to relieve depressive symptoms 👉BrainBehavImm sciencedirect.com/science/articl…

.Emelie Lassén presenting at the Am Soc Nephrology American Physiological Society Basic #Research Forum for Emerging Kidney Scientists

'Targeting podocyte cytotoxic factor with antisense oligonucleotides'

Ilse Daehn, PhD Mount Sinai Department of Medicine

#Nephrology

Congratulations Dr. Siobhan Sundel, recipient of The Cullman Family Award, which honors Mount Sinai Health System physicians across who demonstrate exceptional communication in clinical practice. Recipients rank among the top 1% nationally in the Clinician & Group Survey (CG-CAHPS).

Join us to learn more about surgical innovations, best practices to optimize patient outcome, the future of digital surgery, and more. Registration is open to physicians, physicians assistants, registered nurses and nurse practitioners: mshs.co/3MaiMl2

Students at Icahn School of Medicine at Mount Sinai are more than future doctors. They are dynamic and multi-faceted, and sometimes even possess dual-identities. The SPLIT Series highlights their lives beyond the white coat: morethandocs.co #MoreThanDocs

✨CONGRATULATIONS to Caleb Browne on his appointment to Instructor at Icahn School of Medicine at Mount Sinai's #NashNeuroscience . Dr Browne's research examines how #Brain coordinates goal-directed behavior & how motivational dysfunctions underlie aspects of #PsychiatricDisease w/ focus on #Addiction

Yasmin Hurd, PhD, and Rachel Yehuda, PhD, Icahn School of Medicine at Mount Sinai discuss how neurons from PTSD patients react to stress, unlocking new ways to treat addiction and depression.

Learn more Neuroscience News: neurosciencenews.com/genetics-stres…

Excellent presentation by Gabriele Campanella on large-scale #computationalpathology and different training strategies to build #AI from and for tens of thousands of patients at the HPI.MS retreat. AI & Human Health at Mount Sinai MountSinai Pathology Icahn School of Medicine at Mount Sinai

Rila Therapeutics, founded by John He, MD, PhD, Chief of Nephrology at the Icahn School of Medicine at Mount Sinai announced its emergence out of stealth mode.

Learn more about its promising, first-in-class allosteric small molecule targeting HIPK2 to inhibit kidney fibrosis.

ow.ly/9yrK50Lnmbz

Check out the photos from the MoU signing and announcement of the new partnership with Kathmandu University School of Medical Sciences and Dhulikhel Hospital in Nepal! Learn more by clicking the link below!
mountsinai.org/about/newsroom…

On Monday October 24 2022, Icahn School of Medicine at Mount Sinai hosted the 8th annual Mount Sinai Innovation Awards, celebrating numerous honors that recognize significant contributions in biomedical education and industry. Learn more: mshs.co/3Dvc4TX

Opportunity to join leukemia team at Mount Sinai in NYC as Asst or Assoc Prof with focus on ALL research and care. Large patient population, including underrepresented patients.
mountsinai.org/care/cancer/se…
Contact John Mascarenhas, MD. Icahn School of Medicine at Mount Sinai

Richard Rosen, MD, discusses photobiomodulation, a treatment that applies low levels of light to targeted tissue to decrease inflammation, which might help patients diagnosed with dry age-related macular degeneration: mshs.co/3s0sYDc

Patients with a specific form of age-related macular degeneration, a leading cause of blindness in the US, are at significant risk for cardiovascular disease and stroke, according to new research from the New York Eye and Ear Infirmary of Mount Sinai: mshs.co/3MYQ9HT

Louise Malle, an MD/PhD candidate at Icahn School of Medicine at Mount Sinai, surveyed thousands of patients diagnosed with COVID-19, and essentially found that individuals with the syndrome have about 10 times the likelihood of having extremely severe disease. Learn more: mshs.co/3fi9mYG

Are you a savvy negotiator? How do you handle unfamiliar social situations? Download our app to find out, while contributing to the FIRST NIMH-funded study of its kind on social interaction and mental health.

iOS: mshs.co/3qK4nCl
Android: mshs.co/3qozKSL

Cardinale Smith, MD, PhD discusses how Mount Sinai leads in New York City to increase the diversity of patients in clinical trials: mshs.co/3srfzEI

Researchers at The Tisch Cancer Institute have identified a new gene that is essential to colon cancer growth and found that inflammation in the external environment around the tumor can contribute to the growth of tumor cells: mshs.co/3MEHWIJ